-
Nerandomilast approved by the FDA
The FDA approved Nerandomilast for IPF on Tuesday. Approval for PPF is expected in the coming months. This is the approval of the first new medication for IPF in more than 10 years. Many here in the Pulmonary Fibrosis Forums have anticipated the approval for a long time. The trials are over, and it is now approved.
https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-drug-treat-idiopathic-pulmonary-fibrosis
Will you talk to your care team about whether this drug is right for you?
-
1 Reply
-
Unfortunately, it could be 6 months before it appears on the Medicare formulary.
Log in to reply.